share_log

HC Wainwright & Co. Initiates Coverage On Candel Therapeutics With Buy Rating, Announces Price Target of $11

HC Wainwright & Co. Initiates Coverage On Candel Therapeutics With Buy Rating, Announces Price Target of $11

HC Wainwright&Co.以买入评级启动对Candel治疗公司的报道,宣布目标价为11美元
Benzinga Real-time News ·  2022/12/02 06:32

HC Wainwright & Co. analyst Vernon Bernardino initiates coverage on Candel Therapeutics (NASDAQ:CADL) with a Buy rating and announces Price Target of $11.

HC Wainwright&Co.分析师Vernon Bernardino以买入评级启动对Candel Treateutics(纳斯达克:CADL)的报道,并宣布目标价为11美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发